137 related articles for article (PubMed ID: 32095481)
41. Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes.
Lingvay I; Beetz N; Sennewald R; Schuler-Metz A; Bertulis J; Loley C; Lang B; Lippert C; Lee J; Manning LS; Terada D
Postgrad Med; 2020 May; 132(4):337-345. PubMed ID: 32366156
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetic comparison of gemigliptin 50 mg and metformin 500 mg as a fixed-dose combination and loose combination
.
Lee SW; Park SI; Lee S; Chung JY; Yu KS
Int J Clin Pharmacol Ther; 2019 Feb; 57(2):117-124. PubMed ID: 30574864
[TBL] [Abstract][Full Text] [Related]
43. Bioequivalence evaluation and food effect assessment of Lisinopril/amlodipine tablets in healthy Chinese subjects under fasting and fed conditions.
Li T; Liu YP; Liu SQ; Shi P; Jiang X; Tao Y; Gao XM; Ma YP; Cao Y
BMC Pharmacol Toxicol; 2022 Jul; 23(1):45. PubMed ID: 35794660
[TBL] [Abstract][Full Text] [Related]
44. Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects.
Lee SY; Kim JR; Jung JA; Huh W; Bahng MY; Ko JW
Drug Des Devel Ther; 2015; 9():2811-7. PubMed ID: 26082611
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg
.
Yoon S; Rhee SJ; Park SI; Yoon SH; Cho JY; Jang IJ; Lee S; Yu KS
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):533-539. PubMed ID: 28406090
[TBL] [Abstract][Full Text] [Related]
46. Bioequivalence Study Comparing Fixed-Dose Combination of Clopidogrel and Aspirin with Coadministration of Individual Formulations in Chinese Subjects Under Fed Conditions: A Phase I, Open-Label, Randomized, Crossover Study.
Li Y; Ming JE; Kong F; Yin H; Zhang L; Bai H; Liu H; Qi L; Wang Y; Xie F; Yang N; Ping C; Li Y; Chen L; Han C; Liu J; Wang X
Adv Ther; 2020 Nov; 37(11):4660-4674. PubMed ID: 32970315
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects.
Rhee SJ; Lee S; Yoon SH; Cho JY; Jang IJ; Yu KS
Drug Des Devel Ther; 2016; 10():1411-8. PubMed ID: 27110098
[TBL] [Abstract][Full Text] [Related]
48. Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study.
Li X; Wang C; Li T; Liu Y; Liu S; Tao Y; Ma Y; Gao X; Cao Y
BMC Pharmacol Toxicol; 2020 Nov; 21(1):80. PubMed ID: 33213527
[TBL] [Abstract][Full Text] [Related]
49. The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.
Gu N; Kim BH; Lim KS; Kim SE; Nam WS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2012 Jul; 34(7):1592-600. PubMed ID: 22727611
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: a randomized, open-label, two-period, comparative, crossover study.
Park JY; Kim KA; Park PW; Lee OJ; Ryu JH; Lee GH; Ha MC; Kim JS; Kang SW; Lee KR
Clin Ther; 2006 Nov; 28(11):1837-47. PubMed ID: 17213004
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics of a Fixed-Dose Combination of Teneligliptin Hydrochloride Hydrate and Modified-Release Metformin Under Fasting and Fed Conditions in Healthy Subjects.
Goak IS; Lee JA; Jeong MH; Moon SJ; Kim MG
Drug Des Devel Ther; 2022; 16():4439-4448. PubMed ID: 36597442
[TBL] [Abstract][Full Text] [Related]
52. A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension.
Lee HY; Kim YJ; Ahn T; Youn HJ; Chull Chae S; Seog Seo H; Kim KS; Rhee MY; Choi DJ; Kim JJ; Chun KJ; Yoo BS; Park JS; Oh SK; Kim DS; Kwan J; Ahn Y; Bae Park J; Jeong JO; Hyon MS; Cho EJ; Han KR; Kim DI; Joo SJ; Shin JH; Sung KC; Jeon ES
Clin Ther; 2015 Nov; 37(11):2581-2596.e3. PubMed ID: 25850881
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics and Bioequivalence Evaluation of 2 Olmesartan Medoxomil and Amlodipine Besylate Fixed-Dose Combination Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Li X; Mo E; Chen L
Clin Pharmacol Drug Dev; 2022 Jun; 11(6):761-769. PubMed ID: 35289500
[TBL] [Abstract][Full Text] [Related]
54. Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions.
Wu L; Xu C; Wu G; Zhou H; Lv D; Zhai Y; Huang Y; Tang W; Li F; Shentu J
Drug Des Devel Ther; 2019; 13():3331-3342. PubMed ID: 31571834
[TBL] [Abstract][Full Text] [Related]
55. Bioequivalence assessment of tulobuterol transdermal delivery system in healthy subjects
.
Park SI; Kim BH
Int J Clin Pharmacol Ther; 2018 Aug; 56(8):381-386. PubMed ID: 29932416
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects.
Moon SJ; Jeon JY; Jang K; Yu KS; Lim Y; Kim MG
Drug Des Devel Ther; 2019; 13():2533-2542. PubMed ID: 31440035
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.
Chae DW; Son M; Kim Y; Son H; Jang SB; Seo JM; Nam SY; Park K
Int J Clin Pharmacol Ther; 2015 Oct; 53(10):883-9. PubMed ID: 26329347
[TBL] [Abstract][Full Text] [Related]
58. Simultaneous Analysis of a Combination of Anti-Hypertensive Drugs, Fimasartan, Amlodipine, and Hydrochlorothiazide, in Rats Using LC-MS/MS and Subsequent Application to Pharmacokinetic Drug Interaction with Red Ginseng Extract.
Jeon SY; Jeon JH; Park JH; Lee J; Pang M; Choi MK; Song IS
Toxics; 2022 Sep; 10(10):. PubMed ID: 36287856
[TBL] [Abstract][Full Text] [Related]
59. Bioequivalence Evaluation Between Acarbose and Metformin Fixed-Dose Combination and Corresponding Individual Components in Healthy Chinese Male and Female Subjects.
Liu C; Cleton A; Sui Y; Liu Y; Li J; Yuan F; Sheng L; Xu H; Li X
Clin Pharmacol Drug Dev; 2022 Feb; 11(2):173-184. PubMed ID: 34255938
[TBL] [Abstract][Full Text] [Related]
60. Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability.
Dennison TJ; Smith JC; Badhan RK; Mohammed AR
Drug Des Devel Ther; 2017; 11():811-826. PubMed ID: 28352156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
